CELZ Creative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings, Inc. (CELZ) is expected to report earnings on November 6, 2026, before the market open. The consensus earnings estimate is a loss of $0.24 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -17.0% since its last earnings release on August 7, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Creative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings Inc. is a commercial stage biotechnology company focused on a regenerative approach to Immunotherapy, Urology, Neurology and Orthopedics. Creative Medical Technology Holdings Inc. is based in PHOENIX.
Sector
Healthcare
Industry
Biotechnology